Opus Genetics (IRD) Other financing activities (2020 - 2026)
Opus Genetics (IRD) reported Other financing activities of $100000.0 for Q1 2026, down 92.92% year-over-year from $1.4 million in Q1 2025, and up 2.04% quarter-over-quarter from $98000.0 in Q4 2025.
Opus Genetics (IRD) Other financing activities (2020 - 2026) Analysis & Trends
Opus Genetics (IRD) has 7 years of Other financing activities data on file, last reported at $100000.0 in Q1 2026.
- Other financing activities for Q1 2026 came in at $100000.0, down 92.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $455000.0 (down 71.28% YoY), and the FY2025 annual result was $2.3 million, up 891.81% from the prior year.
- Other financing activities advanced to $100000.0 in Q1 2026 per IRD's latest filing, from $98000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $1.4 million in Q1 2025 and troughed at $12000.0 in Q4 2022.
- A 5-year average of $173933.3 and a median of $98000.0 in 2025 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2022 and 2025: Other financing activities slumped 93.81% in 2022, then soared 2216.39% in 2025.
- A 5-year view of Other financing activities shows it stood at $12000.0 in 2022, then soared by 1333.33% to $172000.0 in 2023, then plunged by 73.26% to $46000.0 in 2024, then surged by 113.04% to $98000.0 in 2025, then advanced by 2.04% to $100000.0 in 2026.
- Business Quant data shows IRD's Other financing activities at $100000.0 in Q1 2026, $98000.0 in Q4 2025, and $100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Opus Genetics | 355.39 Mn | 295.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 98,000.00 |
| Dec 31, 2025 | 98,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 157,000.00 |
| Jun 30, 2025 | 157,000.00 |
| Mar 31, 2025 | 1.41 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 46,000.00 |
| Dec 31, 2024 | 46,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 61,000.00 |
| Mar 31, 2024 | 61,000.00 |
| Dec 31, 2023 | 172,000.00 |
| Dec 31, 2023 | 172,000.00 |